Home Cart 0 Sign in  

[ CAS No. 25691-37-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 25691-37-6
Chemical Structure| 25691-37-6
Structure of 25691-37-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 25691-37-6 ]

Related Doc. of [ 25691-37-6 ]

Alternatived Products of [ 25691-37-6 ]

Product Details of [ 25691-37-6 ]

CAS No. :25691-37-6 MDL No. :MFCD00236841
Formula : C9H18N2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :MDCPCLPRWLKUIQ-LURJTMIESA-N
M.W : 218.25 Pubchem ID :7019666
Synonyms :

Calculated chemistry of [ 25691-37-6 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.78
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 3.0
Molar Refractivity : 54.37
TPSA : 101.65 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.27 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.38
Log Po/w (XLOGP3) : -2.31
Log Po/w (WLOGP) : 0.31
Log Po/w (MLOGP) : 0.01
Log Po/w (SILICOS-IT) : -0.53
Consensus Log Po/w : -0.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.72
Solubility : 1160.0 mg/ml ; 5.3 mol/l
Class : Highly soluble
Log S (Ali) : 0.71
Solubility : 1120.0 mg/ml ; 5.14 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.71
Solubility : 42.4 mg/ml ; 0.194 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.77

Safety of [ 25691-37-6 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P264-P280-P302+P352-P305+P351+P338-P310-P362+P364-P403-P501 UN#:N/A
Hazard Statements:H315-H318 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 25691-37-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 25691-37-6 ]
  • Downstream synthetic route of [ 25691-37-6 ]

[ 25691-37-6 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 13726-85-7 ]
  • [ 25691-37-6 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: With pyridine In water; N,N-dimethyl-formamide at 20℃;
Stage #2: With [bis(acetoxy)iodo]benzene In water; N,N-dimethyl-formamide for 4 h;
To a solution of (S)-5-amino-2-(tert-butoxycarbonylamino)-5-oxopentanoic acid (2g, 8. lmmol) in DMF: water (l : l,v/v, 18ml) was added pyridine (1.3ml, 16.2mmol). The resulting reaction mixture was stirred at room temperature for 5-10 minutes. Iodobenzene diacetate (3.92g, 12. lmmol) was added and further stirred for 4 hours. After completion of reaction D.M. water (100ml) was added and the resulting mixture was extracted with ethyl acetate (3 x 100ml). The combined organic extracts was washed with D.M. water (100ml), brine (100ml), dried over sodium sulphate and concentrated under vacuo to get the desired crude product. The crude product was purified by triturating with diethyl ether. Evaporation of the product fractions gave l .lg (yield, 62percent) of desired compound as brown solid. LC-MS: m/z = 219.1(M+H). [
62% With pyridine; [bis(acetoxy)iodo]benzene In water; N,N-dimethyl-formamide at 20℃; for 4 h; [00383] Step 1 : Preparation of (S)-4-amino-2-(tert-butoxycarbonylamino)butanoic acid [00384] To a solution of (S)-5-amino-2-(tert-butoxycarbonylamino)-5-oxopentanoic acid (2g, 8. lmmol) in DMF: water (l : l,v/v, 18ml) was added pyridine (1.3ml, 16.2mmol). The resulting reaction mixture was stirred at room temperature for 5-10 minutes. Iodobenzene diacetate (3.92g, 12. lmmol) was added and further stirred for 4 hours. After completion of reaction D.M. water (100ml) was added and the resulting mixture was extracted with ethyl acetate (3 x 100ml). The combined organic extracts was washed with D.M. water (100ml), brine (100ml), dried over sodium sulphate and concentrated under vacuo to get the desired crude product. The crude product was purified by triturating with diethyl ether. Evaporation of the product fractions gave l .lg (yield, 62percent) of desired compound as brown solid. LC-MS: m/z = 219.1(M+H).
62%
Stage #1: With pyridine In water; N,N-dimethyl-formamide at 20℃;
Stage #2: for 4 h;
To a solution of (S)-5-amino-2-(tert-butoxycarbo- nylamino)-5-oxopentanoic acid (2 g, 8.1 mmol) in DMF:water (1:1, v/v, 18 ml) was added pyridine (1.3 ml, 16.2 mmol). The resulting reaction mixture was stirred at room temperature for 5-10 minutes. Iodobenzene diacetate (3.92 g, 12.1 mmol) was added and further stirred for 4 hours. After completion of reaction D.M. water (100 ml) was added and the resulting mixture was extracted with ethyl acetate (3x1 00 ml). The combined organic extracts was washed with D.M. water (100 ml), brine (100 ml), dried over sodium sulphate and concentrated under vacuo to get the desired crude product. The crude product was purified by triturating with diethyl ether. Evaporation of the product fractions gave 1.1 g (yield, 62percent) of desired compound as brown solid. LC-MS:mlz=219.1 (M+H).
450 g With [bis(acetoxy)iodo]benzene In tetrahydrofuran; water; ethyl acetate at 0 - 20℃; Large scale Butyloxycarbonyl-L-glutamine 1.2KG, add ethyl acetate 8 liters, tetrahydrofuran 2 liters, water 5 liters, cooled to 0-5 ° C, add iodobenzene diacetate 4.5KG, at room temperature for 12-24 hours, The reaction was completed, the aqueous layer separated, the organic layer washed three times with water, the organic layer was iodobenzene recovery, the combined aqueous layer, vacuum distilled water and absolute ethanol stirred and filtered, washed twice with ethanol, drained, dried at 60 , To obtain N2-tert-butoxycarbonyl-L-2,4-diaminobutyric acid 450 g.

Reference: [1] Synthetic Communications, 2004, vol. 34, # 6, p. 1049 - 1056
[2] Journal of Medicinal Chemistry, 2009, vol. 52, # 15, p. 4650 - 4656
[3] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
[4] Patent: WO2014/151472, 2014, A1, . Location in patent: Paragraph 00340-00341
[5] Patent: WO2016/40315, 2016, A1, . Location in patent: Paragraph 00383; 00384
[6] Patent: US2016/130239, 2016, A1, . Location in patent: Paragraph 0699; 0700
[7] Journal of Organic Chemistry, 2014, vol. 79, # 20, p. 9567 - 9577
[8] Journal of the American Chemical Society, 1997, vol. 119, # 17, p. 4086 - 4087
[9] Chemical and Pharmaceutical Bulletin, 2005, vol. 53, # 9, p. 1152 - 1158
[10] Synthesis (Germany), 2017, vol. 49, # 8, p. 1857 - 1866
[11] Patent: CN106916111, 2017, A, . Location in patent: Paragraph 0056; 0057; 0058; 0077
  • 2
  • [ 117106-21-5 ]
  • [ 25691-37-6 ]
Reference: [1] Patent: WO2013/134660, 2013, A1, . Location in patent: Paragraph 0280
  • 3
  • [ 7536-55-2 ]
  • [ 25691-37-6 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 14, p. 4347 - 4354
  • 4
  • [ 24424-99-5 ]
  • [ 25691-37-6 ]
Reference: [1] Journal of the American Chemical Society, 1997, vol. 119, # 17, p. 4086 - 4087
[2] Patent: CN106916111, 2017, A,
  • 5
  • [ 13726-85-7 ]
  • [ 25691-37-6 ]
  • [ 92235-34-2 ]
Reference: [1] Synthetic Communications, 2008, vol. 38, # 2, p. 162 - 169
  • 6
  • [ 3350-20-7 ]
  • [ 25691-37-6 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1970, vol. 731, p. 152 - 180
  • 7
  • [ 82911-69-1 ]
  • [ 25691-37-6 ]
  • [ 117106-21-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 1, p. 161 - 175
  • 8
  • [ 28920-43-6 ]
  • [ 25691-37-6 ]
  • [ 117106-21-5 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 14, p. 4347 - 4354
  • 9
  • [ 25691-37-6 ]
  • [ 92235-34-2 ]
YieldReaction ConditionsOperation in experiment
54% With sodium hydrogencarbonate; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 12 h; [00202] (S)-tert-Ruiy\ (2-Oxopyrrolidin-3-yl)carbamate (126) To a solution of 0.60 g (2.75 mmol) of BOC-L-DAB-OH in 275 mL of DMF at a 10 mM concentration were added 1.22 g (2.75 mmol) of BOP and 1.16 g (20.0 mmol) of sodium bicarbonate. After 12 h stirring at room temperature, the mixture was concentrated to a small volume (around 5 mL) under reduced pressure. The concentrated mixture was diluted with water and saturated sodium bicarbonate solution (1 : 1, 100 mL) and extracted with three 100- mL portions of EtOAc. The combined organic extracts were washed with 200 mL of water and 200 mL of brine, dried over Na2S04, filtered, and concentrated under reduced pressure to afford a residue that crystallized upon trituration in 100 mL of ether and filtered to afford 126 as a colorless solid: yield 296 mg (54percent); mp 161-164°C (lit/ 168 - 171 °C); silica gel TLC i? 0.55 (10: 1 DCM-MeOH); 'H NMR (CDC13) δ 1.42 (s, 9H), 1.93-2.01 (m, 1H), 2.60-2.70 (m, 1H), 3.28-3.42 (m, 2H), 4.05-4.20 (m, 1H), 5.25 (s, 1H) and 6.85 (br s, 1H); 1 C NMR (CDC13) δ 28.3, 30.0, 39.2, 51.7, 79.9, 155.9 and 176.1.
Reference: [1] Patent: WO2016/118877, 2016, A1, . Location in patent: Paragraph 00202
[2] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 18, p. 2753 - 2758
[3] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3557 - 3571
  • 10
  • [ 13726-85-7 ]
  • [ 25691-37-6 ]
  • [ 92235-34-2 ]
Reference: [1] Synthetic Communications, 2008, vol. 38, # 2, p. 162 - 169
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 25691-37-6 ]

Amino Acid Derivatives

Chemical Structure| 201472-66-4

[ 201472-66-4 ]

Boc-Dab(Boc)-OH.DCHA

Similarity: 0.96

Chemical Structure| 57521-85-4

[ 57521-85-4 ]

(R)-2-((tert-Butoxycarbonyl)amino)pentanoic acid

Similarity: 0.96

Chemical Structure| 2419-94-5

[ 2419-94-5 ]

Boc-Glu-OH

Similarity: 0.96

Chemical Structure| 57133-29-6

[ 57133-29-6 ]

Boc-Orn(Boc)-OH

Similarity: 0.96

Chemical Structure| 6404-28-0

[ 6404-28-0 ]

Boc-Nle-OH

Similarity: 0.96